Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Deloitte
Farmers Insurance
Fish and Richardson
Citi
Teva

Generated: September 15, 2019

DrugPatentWatch Database Preview

Patent: 7,919,322

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,919,322
Title:Targeted deletions using retroelement-mediated placement of recombination sites
Abstract: The present invention provides methods, nucleic acid constructs, and kits for selectively deleting a region of a nucleic acid sequence. Specifically, it utilizes retargeting retroelements to place site-specific recombination sites at targeted locations in the nucleic acid sequence. The region between the recombination sites is then deleted using a site-specific recombination system.
Inventor(s): Spears; Melissa (St. Louis, MO), Davis; Greg (Webster Groves, MO), Kayser; Kevin (Chesterfield, MO)
Assignee: Sigma-Aldrich Co. (St. Louis, MO)
Application Number:11/391,972
Patent Claims:see list of patent claims

Details for Patent 7,919,322

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Sigma-Aldrich Co. (St. Louis, MO) 2037-11-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Sigma-Aldrich Co. (St. Louis, MO) 2037-11-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Sigma-Aldrich Co. (St. Louis, MO) 2037-11-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
McKinsey
Healthtrust
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.